OneSource Specialty Pharma intimated a board meeting on May 13, 2026 to approve audited Q4 and FY26 results.
The trading window for designated persons is closed from April 1, 2026, due to the insider trading code.
The window will reopen 48 hours after the financial results are officially disseminated to the public.